Lower respiratory tract infection caused by Haemophilus influenzae

Drug	Drug Name	Drug Description
DB00537	Ciprofloxacin	A second generation fluoroquinolone used to treat various susceptible bacterial infections.

Drug	Drug Name	Target	Type
DB00537	Ciprofloxacin	DNA gyrase subunit A	target
DB00537	Ciprofloxacin	DNA topoisomerase 4 subunit A	target
DB00537	Ciprofloxacin	DNA topoisomerase 2-alpha	target
DB00537	Ciprofloxacin	Cytochrome P450 1A2	enzyme
DB00537	Ciprofloxacin	Cytochrome P450 3A4	enzyme
DB00537	Ciprofloxacin	Cytochrome P450 3A5	enzyme
DB00537	Ciprofloxacin	Cytochrome P450 3A7	enzyme
DB00537	Ciprofloxacin	P-glycoprotein 1	transporter
DB00537	Ciprofloxacin	Potassium voltage-gated channel subfamily H member 2	target
DB00537	Ciprofloxacin	DNA gyrase subunit A	target
DB00537	Ciprofloxacin	DNA topoisomerase 4 subunit A	target
DB00537	Ciprofloxacin	DNA topoisomerase 4 subunit B	target
DB00537	Ciprofloxacin	DNA gyrase subunit A	target
DB00537	Ciprofloxacin	Multidrug resistance protein MdtK	target
DB00537	Ciprofloxacin	Gyrase A	target
DB00537	Ciprofloxacin	DNA gyrase subunit A	target
DB00537	Ciprofloxacin	Multidrug and toxin extrusion protein 1	transporter
DB00537	Ciprofloxacin	Multidrug and toxin extrusion protein 2	transporter
DB00537	Ciprofloxacin	Serum albumin	carrier

Drug	Drug Name	Phase	Status	Count